158 related articles for article (PubMed ID: 24781818)
1. Accuracy of chemical shift MR imaging in diagnosing indeterminate bone marrow lesions in the pelvis: review of a single institution's experience.
Kohl CA; Chivers FS; Lorans R; Roberts CC; Kransdorf MJ
Skeletal Radiol; 2014 Aug; 43(8):1079-84. PubMed ID: 24781818
[TBL] [Abstract][Full Text] [Related]
2. Benign and malignant processes: normal values and differentiation with chemical shift MR imaging in vertebral marrow.
Zajick DC; Morrison WB; Schweitzer ME; Parellada JA; Carrino JA
Radiology; 2005 Nov; 237(2):590-6. PubMed ID: 16244268
[TBL] [Abstract][Full Text] [Related]
3. Differentiation of focal indeterminate marrow abnormalities with multiparametric MRI.
Baik JS; Jung JY; Jee WH; Chun CW; Kim SK; Shin SH; Chung YG; Jung CK; Kannengiesser S; Sohn Y
J Magn Reson Imaging; 2017 Jul; 46(1):49-60. PubMed ID: 27859835
[TBL] [Abstract][Full Text] [Related]
4. Chemical shift MRI can aid in the diagnosis of indeterminate skeletal lesions of the spine.
Douis H; Davies AM; Jeys L; Sian P
Eur Radiol; 2016 Apr; 26(4):932-40. PubMed ID: 26162578
[TBL] [Abstract][Full Text] [Related]
5. Value of opposed-phase gradient-echo technique in distinguishing between benign and malignant vertebral lesions.
Zampa V; Cosottini M; Michelassi C; Ortori S; Bruschini L; Bartolozzi C
Eur Radiol; 2002 Jul; 12(7):1811-8. PubMed ID: 12111073
[TBL] [Abstract][Full Text] [Related]
6. Role of in-phase and out-of-phase chemical shift MRI in differentiation of non-neoplastic versus neoplastic benign and malignant marrow lesions.
van Vucht N; Santiago R; Pressney I; Saifuddin A
Br J Radiol; 2021 Mar; 94(1119):20200710. PubMed ID: 33571012
[TBL] [Abstract][Full Text] [Related]
7. An imaging algorithm for the differential diagnosis of adrenal adenomas and metastases.
McNicholas MM; Lee MJ; Mayo-Smith WW; Hahn PF; Boland GW; Mueller PR
AJR Am J Roentgenol; 1995 Dec; 165(6):1453-9. PubMed ID: 7484585
[TBL] [Abstract][Full Text] [Related]
8. Measurement of fat content in vertebral marrow using a modified dixon sequence to differentiate benign from malignant processes.
Yoo HJ; Hong SH; Kim DH; Choi JY; Chae HD; Jeong BM; Ahn JM; Kang HS
J Magn Reson Imaging; 2017 May; 45(5):1534-1544. PubMed ID: 27690264
[TBL] [Abstract][Full Text] [Related]
9. Current concepts in MRI of focal and diffuse malignancy of bone marrow.
Howe BM; Johnson GB; Wenger DE
Semin Musculoskelet Radiol; 2013 Apr; 17(2):137-44. PubMed ID: 23673545
[TBL] [Abstract][Full Text] [Related]
10. In-phase and out-of-phase MR imaging of bone marrow: prediction of neoplasia based on the detection of coexistent fat and water.
Disler DG; McCauley TR; Ratner LM; Kesack CD; Cooper JA
AJR Am J Roentgenol; 1997 Nov; 169(5):1439-47. PubMed ID: 9353477
[TBL] [Abstract][Full Text] [Related]
11. Does the presence of focal normal marrow fat signal within a tumor on MRI exclude malignancy? An analysis of 184 histologically proven tumors of the pelvic and appendicular skeleton.
Simpfendorfer CS; Ilaslan H; Davies AM; James SL; Obuchowski NA; Sundaram M
Skeletal Radiol; 2008 Sep; 37(9):797-804. PubMed ID: 18551289
[TBL] [Abstract][Full Text] [Related]
12. Diffusion-weighted MRI for differentiation of benign from malignant lesions in the gallbladder.
Lee NK; Kim S; Kim TU; Kim DU; Seo HI; Jeon TY
Clin Radiol; 2014 Feb; 69(2):e78-85. PubMed ID: 24290779
[TBL] [Abstract][Full Text] [Related]
13. Advanced MR imaging of bone marrow: quantification of signal alterations on T1-weighted Dixon and T2-weighted Dixon sequences in red marrow, yellow marrow, and pathologic marrow lesions.
Sasiponganan C; Yan K; Pezeshk P; Xi Y; Chhabra A
Skeletal Radiol; 2020 Apr; 49(4):541-548. PubMed ID: 31606776
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic performance of ADC for Non-mass-like breast lesions on MR imaging.
Imamura T; Isomoto I; Sueyoshi E; Yano H; Uga T; Abe K; Hayashi T; Honda S; Yamaguchi T; Uetani M
Magn Reson Med Sci; 2010; 9(4):217-25. PubMed ID: 21187691
[TBL] [Abstract][Full Text] [Related]
15. Characterization of indeterminate soft tissue masses referred for biopsy: What is the added value of contrast imaging at 3.0 tesla?
Del Grande F; Ahlawat S; Subhawong T; Fayad LM
J Magn Reson Imaging; 2017 Feb; 45(2):390-400. PubMed ID: 27417663
[TBL] [Abstract][Full Text] [Related]
16. T2-weighted MR imaging in the assessment of cirrhotic liver.
Hussain HK; Syed I; Nghiem HV; Johnson TD; Carlos RC; Weadock WJ; Francis IR
Radiology; 2004 Mar; 230(3):637-44. PubMed ID: 14739306
[TBL] [Abstract][Full Text] [Related]
17. Proton density fat fraction (PDFF) MR imaging for differentiation of acute benign and neoplastic compression fractures of the spine.
Schmeel FC; Luetkens JA; Enkirch SJ; Feißt A; Endler CH; Schmeel LC; Wagenhäuser PJ; Träber F; Schild HH; Kukuk GM
Eur Radiol; 2018 Dec; 28(12):5001-5009. PubMed ID: 29858641
[TBL] [Abstract][Full Text] [Related]
18. Good interrater reliability of a new grading system in detecting traumatic bone marrow lesions in the knee by dual energy CT virtual non-calcium images.
Cao JX; Wang YM; Kong XQ; Yang C; Wang P
Eur J Radiol; 2015 Jun; 84(6):1109-15. PubMed ID: 25816992
[TBL] [Abstract][Full Text] [Related]
19. Adding in vivo quantitative 1H MR spectroscopy to improve diagnostic accuracy of breast MR imaging: preliminary results of observer performance study at 4.0 T.
Meisamy S; Bolan PJ; Baker EH; Pollema MG; Le CT; Kelcz F; Lechner MC; Luikens BA; Carlson RA; Brandt KR; Amrami KK; Nelson MT; Everson LI; Emory TH; Tuttle TM; Yee D; Garwood M
Radiology; 2005 Aug; 236(2):465-75. PubMed ID: 16040903
[TBL] [Abstract][Full Text] [Related]
20. Lesion type and reader experience affect the diagnostic accuracy of breast MRI: a multiple reader ROC study.
Baltzer PAT; Kaiser WA; Dietzel M
Eur J Radiol; 2015 Jan; 84(1):86-91. PubMed ID: 25466772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
